IDEAYA Biosciences Issues Stock Options to New Hires

The Compensation Committee authorized the purchase of 94,000 shares of common stock under the 2023 Employment Inducement Incentive Award Plan. These options carry an exercise price of $36.74 per share, matching the closing market price on the date of the grant. The structure of the award includes a 10-year term and a four-year vesting schedule. One-quarter of the total options will vest on the first anniversary of the commencement date, with the remainder vesting in equal monthly installments over the following three years, contingent upon continued service to the firm.